Article
Increased RCAS1 Expression Is Associated with Advanced Histopathological Stage and Poor…
Disease Markers · 2013 · Constantinos Giaginis, author Themistoclis Efkarpidis, author Paraskevi Alexandrou, author Efstratios Patsouris, author Gregory Kouraklis, author Stamatios Theocharis, author Sun-Il Hwang, Academic Editor
Key facts
| Title | Increased RCAS1 Expression Is Associated with Advanced Histopathological Stage and Poor Prognosis in Patients with Gastric Adenocarcinoma |
|---|---|
| First author | Constantinos Giaginis, author Themistoclis Efkarpidis, author Paraskevi Alexandrou, author Efstratios Patsouris, author Gregory Kouraklis, author Stamatios Theocharis, author Sun-Il Hwang, Academic Editor |
| Journal | Disease Markers |
| Published | Jun 29, 2013 |
| DOI | 10.1155/2013/527548 |
| Devices mentioned | K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184, K854185, K854186, K854187 and 1 more |
| Product codes mentioned | CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, KLB, KLS and 4 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1